Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a laser beam silence stubborn hip pain?

NCT ID NCT07749066

Symptom relief Sponsor: Ankara Etlik City Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This trial tests whether high-intensity laser therapy can reduce pain and improve function in people with greater trochanteric pain syndrome, a common cause of lateral hip pain. Participants receive either real laser treatment or a sham version over 10 sessions, alongside a home exercise program. The study measures changes in pain intensity, pressure sensitivity, and quality of life to see if the laser offers real benefit beyond a placebo effect.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
High-intensity laser therapy (HILT) using a pulsed Nd:YAG laser device
What this could lead to
If effective, this non-invasive treatment could offer a drug-free option to reduce hip pain and improve daily function for people with greater trochanteric pain syndrome.
What could go wrong
The trial is small and early, and results may not apply to everyone. The sham comparison helps, but benefits could be modest or short-lived, and individual responses may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 64 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 to 80 years * Patients diagnosed with Greater Trochanteric Pain Syndrome (GTPS) based on clinical examination * Presence of symptoms for at least 3 months * Pain intensity ≥4 on the Visual Analog Scale (VAS) * No corticosteroid injection or other conservative treatment within the last 3 months Exclusion Criteria: * Hip fracture, tumor, infection, or advanced osteoarthritis * Contraindications to high-intensity laser therapy (e.g., pacemaker, pregnancy, coagulation disorders, anticoagulant therapy, neoplasia, history of epilepsy) * Contraindications to physical activity (e.g., ischemic heart disease, arrhythmia, uncontrolled hypertension, heart failure, severe respiratory insufficiency) * Peripheral vascular disorders (e.g., thrombophlebitis, thrombosis, lymphedema) * History of trauma within the last 3 months or prior surgery involving the lower extremity or lumbar spine * Neurological disorders or chronic inflammatory diseases

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Greater trochanteric pain syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Greater trochanteric pain syndrome

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Etlik City Hospital

    RECRUITING

    Ankara, Yenimahalle, 06370, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.